Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|8|1054-1058

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.8, 2015-06, pp. : 1054-1058

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: Is it necessary for all patients?

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 4, 2015-04 ,pp. : 439-444

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 212-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can Dynamic MR Imaging Predict Response in Patients with Rectal Cancer Undergoing Cetuximab-Based Neoadjuvant Chemoradiation?

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

Optimizing the selection of patients with low rectal cancer for intersphincteric resection by evaluating vertical invasion to the levator and external sphincter

By  

COLORECTAL DISEASE, Vol. 17, Iss. 2, 2015-02 ,pp. : 133-140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicentre study of robotic intersphincteric resection for low rectal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 12, 2015-11 ,pp. : 1567-1573

John Wiley & Sons Inc

Access to resources Recommend Favorite